This year, like most others in recent memory, medical plan costs are up by as much as 7%. A International Foundation of Employee Benefit Plans survey found that they are paced by: utilization related ...

Artificial intelligence (AI) is rapidly transforming clinical trials by dramatically reducing timelines and costs, accelerating patient-centered drug development and creating more resilient and ...

REDCap Cloud harmonizes real-world evidence and trial data to overcome the industry’s biggest data management challenges; lays the foundation for AI-driven research nPhase, Inc., an innovator of cloud ...

Qureight, a techbio company accelerating drug development using its proprietary deep-learning image biomarkers and clinical data analytics platform, today announced the first results from a ...

The global market for clinical data analytics is expected to grow at a compound annual growth rate of 12.5 percent by 2023, according to a Market Research Future report. Clinical data analytics ...

The complex and costly journey of oncology drug development is reliant on robust and comprehensive clinical data. Early-stage ...

Healthcare revenue cycle management company Alpha II has acquired clinical data analytics company Health eFilings. Alpha II CEO Todd Dooze will lead the combined Health eFilings and Alpha II entity, ...

EssilorLuxottica buys RetinAI to boost AI-powered eyecare and data analytics, accelerating innovation in visual health screening ...

PIK3CA mutant cohort of the Phase 3 VIKTORIA-1 clinical trial is fully enrolledAdditional analysis of data from a Phase 1b clinical trial that included all patients treated with gedatolisib combined ...

TYK Medicines, Inc. Class H ( ($HK:2410) ) has provided an announcement. TYK Medicines, Inc announced positive early-phase clinical study results ...